Literature DB >> 16169218

Discovery of 1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selectivity between human melanocortin-4 and -1 receptors in linear pentapeptides.

Xin-Jie Chu1, David Bartkovitz, Waleed Danho, Joseph Swistok, Adrian Wai-Hing Cheung, Grazyna Kurylko, Karen Rowan, Mitch Yeon, Lucia Franco, Lida Qi, Li Chen, Keith Yagaloff.   

Abstract

Linear pentapeptides (Penta-cis-Apc-DPhe-Arg-Trp-Gly-NH2) containing 1-amino-4-phenylcyclohexane-1-carboxylic acid (cis-Apc) and substituted Apc are potent hMC4R agonists and they are inactive or weakly active in hMC1R, hMC3R, and hMC5R agonist assays. This study, together with our earlier report on 5-BrAtc, demonstrated the importance of replacing His6 with phenyl-containing rigid templates in achieving good hMC4R agonist potency and selectivity against hMC1R in linear pentapeptides.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169218     DOI: 10.1016/j.bmcl.2005.08.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.

Authors:  Mithun R Raje; Kenneth Knott; Yugesh Kharel; Philippe Bissel; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2011-11-15       Impact factor: 3.641

2.  Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids.

Authors:  Jianbo Wu; Xiaofang Wang; Francis C K Chiu; Cécile Häberli; David M Shackleford; Eileen Ryan; Sriraghavan Kamaraj; Vivek J Bulbule; Alexander I Wallick; Yuxiang Dong; Karen L White; Paul H Davis; Susan A Charman; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2020-03-19       Impact factor: 7.446

3.  Diethyl 4-hy-droxy-4-methyl-6-oxo-2-phenyl-cyclo-hexane-1,3-dicarboxyl-ate.

Authors:  Hoong-Kun Fun; Madhukar Hemamalini; Mahesh Padaki; Arun M Isloor
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.